Celcuity (CELC) Depreciation & Amortization (CF) (2016 - 2025)
Celcuity (CELC) posted Depreciation & Amortization (CF) of $49000.0 for Q4 2025, up 19.51% on a QoQ basis from $41000.0 in Q3 2025, and up 40.0% year-over-year from $35000.0 in Q4 2024.
Celcuity (CELC) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends
Celcuity's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $49000.0 for Q4 2025.
- Quarterly Depreciation & Amortization (CF) rose 40.0% year-over-year to $49000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $167000.0 (up 28.46% YoY) and the FY2025 annual result came in at $167000.0, up 28.46% from the prior year.
- Depreciation & Amortization (CF) was $49000.0 for Q4 2025 at Celcuity, up from $41000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $98222.0 in Q1 2021 and bottomed at $27948.0 in Q4 2023.
- A 5-year average of $47696.2 and a median of $42469.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) sank 43.0% — and 2025, when it jumped 40.0%.
- Celcuity's Depreciation & Amortization (CF) stood at $63029.0 in 2021, then slipped by 22.36% to $48937.0 in 2022, then sank by 42.89% to $27948.0 in 2023, then increased by 25.23% to $35000.0 in 2024, then soared by 40.0% to $49000.0 in 2025.
- Business Quant data shows CELC's Depreciation & Amortization (CF) at $49000.0 in Q4 2025, $41000.0 in Q3 2025, and $40000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 49,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 27,948.00 |
| Dec 31, 2023 | 27,948.00 |
| Sep 30, 2023 | 33,555.00 |
| Sep 30, 2023 | 33,555.00 |